logo

Neurobo Pharmaceuticals, Inc. (NRBO)



Trade NRBO now with
  Date
  Headline
1/18/2023 8:09:04 AM NeuroBo Pharma Appoints Joseph Hooker As Interim CEO And President
9/15/2022 8:38:06 AM NeuroBo Collaborates To License And Develop Portfolio Of Dong-A's Cardio-Metabolic Therapies; Stock Surges
9/12/2022 9:20:38 AM NeuroBo Pharmaceuticals Announces 1-for-30 Reverse Split Of Common Stock
9/12/2022 9:15:00 AM NeuroBo Pharmaceuticals Announces Reverse Stock Split (Press Release)
5/6/2022 8:10:22 AM NeuroBo Pharma Appoints Matthew Bardin As SVP Operations
4/1/2022 8:06:53 AM NeuroBo Pharma FY Net Loss $15.3 Mln Or $0.66/shr Vs Net Loss Of $29.7 Mln, Or $1.83/shr Last Year
11/15/2021 8:09:44 AM NeuroBo Pharmaceuticals Q3 Net Loss $3.5 Mln Or $0.16/shr Vs. Net Loss $3.1 Mln Or $0.19/shr Last Year